MedPath

Development and validation of an algorithm for an ultra low-power miniaturized device with accelerometry, electrocardiography and electromyography based tonic seizure detection.

Completed
Conditions
Epilepsy
10039911
Registration Number
NL-OMON47184
Lead Sponsor
Epilepsiecentrum Kempenhaeghe
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
30
Inclusion Criteria

Patients who meet all of the following criteria are eligible for this study:
- Currently residing at Providentia (long stay facilities of Kempenhaeghe)
- Over 18 years of age
- Nightly tonic and/or tonic-clonic seizures
- Minimal seizure frequency: 1/week
- Informed consent form signed by legal representatives

Exclusion Criteria

Subjects meeting one or more of the following criteria cannot be selected:
- History of heart failure, significant heart disease or, obstructive sleep apnea
- Drugs or pacemakers that significantly influence heart rate (for example beta-blockers)
- Inability to comply with the test procedure
- Inability to tolerate the used electrodes

Study & Design

Study Type
Observational non invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>The primary study parameter is the added value of electromyography analysis to<br /><br>the analysis of heartrate and accelerometry. </p><br>
Secondary Outcome Measures
NameTimeMethod
<p>Secondary study parameters are analysis of heartrate and accelerometry,<br /><br>comparison to the Emfit bed sensor and quality of life. </p><br>
© Copyright 2025. All Rights Reserved by MedPath